--
Related Articles
Research
Deutsche Bank Upgrades DaVita to Buy From Hold, Raises Price Target to $220 From $126
DaVita (DVA) has an average rating of hold and mean price target of $169.17, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$DVA
Research
Rothschild & Co Redburn Upgrades Monster Beverage to Buy From Neutral, Raises Price Target to $90 From $76
Monster Beverage (MNST) has an average rating of overweight and mean price target of $89.05, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$MNST
Research
RBC Adds Speculative Risk to Outperform Rating on Cytokinetics, Lifts Price Target to $119 From $101
Cytokinetics (CYTK) has an average rating of buy and mean price target of $100.37, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$CYTK